United States · Business magazines · Quartz

Lycia Therapeutics stock surges in IPO debut after pricing about $317.5M offering

Published by Quartz · United States 1 h ago

The drug developer priced 17.64 million shares at $18 each, and the offering is expected to close on Oct. 26

Read the full article on Quartz Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (qz.com)

Also worth reading

PE Hub Lasted 20 Years. Now Its Founder Dan Primack Says the Brand Has ‘Met Its Maker’

Let 17-year-olds change their minds. In the age of AI, it’s their best career move

First Pillsbury and Trader Joe’s. Now another food brand is recalling products over glass concerns

Markets Insider (Business Insider)

Oregon Bancorp GAAP EPS of $0.30, revenue of $4.87M

9 Changes to Social Security in 2027

AI Cybersecurity Risks: What’s Overhyped And What’s Overlooked